MedTrace Logo

Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19

NCT04355533 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1056

Last updated 2026-01-06

No results posted yet for this study

Summary

The purpose of this study is to provide data on the proportion of seroconverted children and their immune status. It will also provide insight into the number of children currently infected at each time point including healthy carriers. Investigators will provide similar data on their parents in an ancillary study.

Conditions

  • COVID-19 Infection

Interventions

BIOLOGICAL

serology test

volume according to child weight

BIOLOGICAL

nasopharyngeal swab

nasopharyngeal swab for PCR

BIOLOGICAL

rectal swab

rectal swab for PCR

BIOLOGICAL

saliva sample

for biocollection

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Commissariat A L'energie Atomique

    collaborator OTHER_GOV

  • Institut Pasteur

    collaborator INDUSTRY

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Isabelle SERMET-GAUDELUS, MD, PhD · Assistance Publique-Hôpitaux de Pars

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-29
Primary Completion
2022-05-20
Completion
2022-05-24

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04355533 on ClinicalTrials.gov